Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
API plant
Manufacturing
Lilly weighs Houston as option for new $5.9B API facility
Eli Lilly is jockeying for a tax break in Texas as it weighs whether to build a $5.9 billion API facility in Houston, according to a state filing.
Fraiser Kansteiner
May 19, 2025 10:21am
Xellia to shutter Copenhagen antibiotics plant over next decade
May 7, 2025 9:40am
AbbVie plots $10B US outlay as pharma tariff threat looms
Apr 25, 2025 11:52am
Evotec offloads chemical API facility for undisclosed price
Nov 7, 2024 8:04am
Lilly to spend $4.5B for Indiana R&D and manufacturing site
Oct 2, 2024 8:55am
SK pharmteco to build $260M peptide production plant in Korea
Sep 30, 2024 3:46pm
